Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations

Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations

Patients with chronic obstructive pulmonary disease (COPD) frequently develop exacerbations, leading to major clinical and healthcare utilisation ramifications. Exacerbations, especially those that result in hospitalisation, are the main cost driver in COPD and frequent exacerbations are associated...

Full description

Bibliographic Details
Main Author:	R. Rodríguez-Roisin
Format:	Article
Language:	English
Published:	European Respiratory Society 2006-12-01
Series:	European Respiratory Review
Subjects:	Bronchodilators chronic obstructive pulmonary disease exacerbations healthcare utilisation hospitalisation long-acting anticholinergic agents
Online Access:	http://err.ersjournals.com/cgi/content/full/15/99/47

Similar Items

Reducing cholinergic constriction: the major reversible mechanism in COPD
by: V. Brusasco
Published: (2006-12-01)

GOLD severity stratification and risk of hospitalisation for COPD exacerbations
by: M. Lusuardi, et al.
Published: (2016-01-01)

Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation - The Italian SOS (Stratification Observational Study)
by: M. Lusuardi, et al.
Published: (2016-01-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Prevention of exacerbations of COPD with pharmacotherapy
by: M. Miravitlles
Published: (2010-06-01)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
by: Wedzicha JA, et al.
Published: (2017-01-01)

Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD
by: Dalal Anand A, et al.
Published: (2012-05-01)

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD
by: Mahoto Kato, et al.
Published: (2017-12-01)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
by: Halpin DMG, et al.
Published: (2017-10-01)

COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01)

COPD exacerbation: factors influencing hospitalization duration.
by: K. Yu. Gashynova
Published: (2015-03-01)

Exercise and dyspnoea in COPD
by: P. M. A. Calverley
Published: (2006-12-01)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
by: Se Hee Lee, et al.
Published: (2019-03-01)

Exacerbations of COPD
by: Pavord ID, et al.
Published: (2016-02-01)

Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance
by: D. E. O'Donnell
Published: (2006-12-01)

Treatment of COPD exacerbations: antibiotics
by: R. Wilson
Published: (2005-09-01)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
by: Lin CM, et al.
Published: (2020-02-01)

Treatment after a COPD exacerbation
by: Robbins RA
Published: (2013-07-01)

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
by: Hsieh MJ, et al.
Published: (2018-09-01)

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
by: Domenico Lorenzo Urso
Published: (2017-07-01)

The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study
by: Larsson K, et al.
Published: (2021-03-01)

Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study
by: Danilo Cortozi Berton, et al.

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
by: Jo YS, et al.
Published: (2017-12-01)

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
by: Anthony D’Urzo, et al.
Published: (2019-03-01)

Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)
by: James D. Chalmers, et al.
Published: (2018-04-01)

Impact of exacerbations on COPD
by: A. Anzueto
Published: (2010-06-01)

Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk
by: Chi-Tai Lee, et al.
Published: (2021-07-01)

Comparison of Tetropium and β2 Agonist Therapy in Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
by: Hamidreza Dehghan, et al.
Published: (2017-09-01)

Investigation of the efficacy of generic and brand-name tiotropium bromide in the management of chronic obstructive pulmonary disease: A randomized comparative trial
by: Yunes Panahi, et al.
Published: (2016-03-01)

Hospitalisation rates and predictors in people with dementia: a systematic review and meta-analysis
by: Hilary Shepherd, et al.
Published: (2019-07-01)

Experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2021-01-01)

Analisi di costo efficacia nella terapia della BPCO
by: Sergio Iannazzo, et al.
Published: (2005-12-01)

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
by: Bateman Eric D, et al.
Published: (2011-04-01)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
by: Vogelmeier CF, et al.
Published: (2021-08-01)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
by: Tashkin DP, et al.
Published: (2018-06-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study
by: Plate T, et al.
Published: (2020-06-01)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
by: Nina S. Godtfredsen, et al.
Published: (2018-05-01)

Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients
by: Jeong SH, et al.
Published: (2016-08-01)

Factors associated with exacerbation in mild-to-moderate COPD patients
by: Kim JK, et al.
Published: (2016-06-01)